These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6392488)

  • 1. Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumors.
    Hartmann O; Oberlin O; Lemerle J; Maraninchi D; Gastaut JA; Mascret B; Sebahoun G; Carcassonne Y
    J Clin Oncol; 1984 Dec; 2(12):1424-5. PubMed ID: 6392488
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
    Maraninchi D; Abecasis M; Gastaut JA; Herve P; Sebahoun G; Flesch M; Blanc AP; Carcassonne Y
    Cancer Treat Rep; 1984 Mar; 68(3):471-4. PubMed ID: 6367977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan.
    Kingston JE; Malpas JS; Stiller CA; Pritchard J; McElwain TJ
    Br J Haematol; 1984 Dec; 58(4):589-95. PubMed ID: 6394042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
    Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
    Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
    Phillips GL; Shepherd JD; Barnett MJ; Lansdorp PM; Klingemann HG; Spinelli JJ; Nevill TJ; Chan KW; Reece DE
    J Clin Oncol; 1991 Oct; 9(10):1880-8. PubMed ID: 1919638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated high-dose-melphalan with autologous bone marrow transplantation in acute non lymphocytic leukemia.
    Mascret B; Maraninchi D; Gastaut JA; Camerlo J; Novakovitch G; Perrimond H; Sebahoun G; Lepeu G; Rossi F; Carcassonne Y
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):477-88. PubMed ID: 3912925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
    Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
    J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
    Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
    Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
    Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia.
    Martino R; Badell I; Brunet S; Sureda A; Torras A; Cubells J; Domingo-Albós A
    Bone Marrow Transplant; 1995 Aug; 16(2):209-12. PubMed ID: 7581138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
    Leff RS; Thompson JM; Johnson DB; Mosley KR; Daly MB; Knight WA; Ruxer RL; Messerschmidt GL
    J Clin Oncol; 1986 Nov; 4(11):1586-91. PubMed ID: 3534154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
    de Kraker J; Voûte PA; Behrendt H
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dosage melphalan followed by bone marrow autotransplant in solid tumors of childhood: our experience].
    Sánchez de Toledo Codina J; Gallego Melcón S; Pérez Payarols J; Prats Viñas J; Javier G; Massuet L; Macià Martí J
    Med Clin (Barc); 1986 Apr; 86(15):621-3. PubMed ID: 3014240
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantation.
    Slichenmyer WJ; LeMaistre CF; Von Hoff DD
    Invest New Drugs; 1992 Apr; 10(1):45-8. PubMed ID: 1318872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission.
    Keating A; Crump M
    Leukemia; 1992 Nov; 6 Suppl 4():90-1. PubMed ID: 1434843
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
    Lazarus HM; Herzig RH; Wolff SN; Phillips GL; Spitzer TR; Fay JW; Herzig GP
    Cancer Treat Rep; 1985 May; 69(5):473-7. PubMed ID: 3891085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias.
    Maraninchi D; Pico JL; Hartmann O; Gastaut JA; Kamioner D; Hayat M; Mascret B; Beaujean F; Sebahoun G; Novakovitch G
    Cancer Treat Rep; 1986 Apr; 70(4):445-8. PubMed ID: 3516394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.